While AD transgenic mice without MSC-exosomes displayed an increase in reactive astrocytes until 10 months of age, the expression of GFAP decreased significantly in MSC-exosomes-treated Tg mice (Figure 5C and Figure S5A). This evidence concerns the gene GFAP and Alzheimer disease.